Rebalix
iShares · sheet of 5 September 2026
iShares · sheet of 5 September 2026ETF sheet · official issuer and register data
iShares MSCI Japan SRI UCITS ETF
SUJP · IE00BYX8XC17 · USD · domicile Ireland
Equity · Japan · Large & mid cap · Sustainable / ESGSFDR art. 8
Index tracked: MSCI Japan SRI Select Reduced Fossil Fuel Index (USD)
- TER
- 0.20%+ trans. 0.02%
- Fund size
- 458 m EUR
- Tracking difference
- −0.19%3-year avg
- 🇮🇹 tax rate
- 25.98%white list 0.14%
- Replication
- Physical (full replication)
- Income
- Accumulating
Launch 6 Mar 2017 · costs from the KID as of 2 Sept 2026 · 40 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income, which reflect the return of the MSCI Japan SRI Select Reduced Fossil Fuel Index, (the “Index”). The Share Class, via the Fund, is passively managed and aims to invest in the equity securities , so far as possible and practicable, that make up the Index. The Index measures the performance of a sub-set of equity securities issued by Japanese companies within the MSCI Japan Index ("Parent Index") with higher…
Performance since series start (in euro) — base 100
2 Mar 2017 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +20.8% |
| 3 years | +39.0% |
| 5 years | +30.9% |
| 10 years | series too young |
| Since series start | +73.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 18.87% | 21.23% | 20.07% |
| Max drawdown | −13.23% | −19.18% | −35.11% |
| Sharpe | 1.11 | 0.58 | 0.20 |
| Sortino | 1.73 | 0.85 | 0.28 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SUJP · IE00BYX8XC171
RebalixSUJP · IE00BYX8XC17 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +17.76% | +17.96% | −0.21% |
| 2024 | +3.84% | +4.04% | −0.19% |
| 2023 | +13.10% | +13.28% | −0.18% |
| 2022 | −18.09% | −17.93% | −0.16% |
| 2021 | +1.51% | +1.68% | −0.18% |
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 40 securities · top-10 weight = 54.7%
| Top holdings | Weight |
|---|---|
| 6.7% | |
| 6.5% | |
| 6.4% | |
| 6.3% | |
| 6.3% | |
| 5.1% | |
| 4.9% | |
| 4.3% | |
| 4.2% | |
| 4.1% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
SUJP · Borsa Italiana (ETFplus), Euronext Amsterdam
SXR6 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BYX8XC17
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BYX8XC17
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · SUJP · IE00BYX8XC172